Moreover, in animal models of adult-onset hepatic GH resistance, steatosis and NASH evolve rapidly after the loss of hepatic GH signaling, regardless of other signs of metabolic dysfunction [25]. The gene discussed is GH1; the disease is metabolic dysfunction-associated steatohepatitis.